Your personal result will depend on your starting weight, diet, activity level, and how your body responds to tirzepatide
Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: Impact of preserved small nerve fiber function
Common injection sites include: Abdomen (at least 2 inches from the navel) Upper thigh (front or outside) Upper arm (back of arm, may require assistance) Expected weight loss from injections Results vary based on dose, starting weight, lifestyle factors, and individual biology, but clinical trial data provide reliable expectations
Step 3: After the injection After the injection, you can follow these steps: Gently remove the needle at the same angle at which you inserted it